Advertisement

Classification of dementias based on functional morphology

  • K. A. Jellinger
  • C. Bancher
Part of the Key Topics in Brain Research book series (KEYTOPICS)

Summary

Dementia syndromes in adults can be caused by many different conditions that find their pathological correlates in seven major groups of CNS disorders: 1. presenile and senile dementia of the Alzheimer type (AD/DAT), the diagnosis of which is based on quantitative assessment of neuritic changes — neuritic plaques, neurofibrillary tangles — probably representing end-stage markers or epiphenomena of primary neuronal degeneration of hitherto unknown origin; 2. other degenerative diseases, e.g. Parkinson’s disease associated with AD, Diffuse Lewy body disease, Pick’s lobar atrophy, Huntington’s disease, progressive supranuclear palsy, corticobasal degeneration, and multiple system atrophies; 3. vascular dementia (VD) with several subtypes — multiinfarct encephalopathy, strategic and small vessel infarct dementia (multilacunar state, subcortical type Binswanger, granular cortical atrophy); 4. mixed type dementia (MIX) due to coexistence of AD/DAT and vascular pathologies; 5. Prion diseases or transmissible spongiform encephalopathies (e.g. Creutzfeldt-Jakob disease); 6. normal pressure hydrocephalus; 7. various organic brain diseases, such as tumors, chronic infections, alcoholic and metabolic encephalopathies. In large autopsy series, AD/DAT account for 70 to 80%, VD and MIX for 8 to 10%, each while the remaining disorders are of minor importance. While most cohorts show VD as the second most frequent type of dementia, in some series it is Lewy body dementia. In a personal consecutive postmortem series of 1200 aged subjects (mean age 79.5% years), 78% fulfilled the pathologic criteria for AD, but only 43% were “pure” forms, 15.5% had additional minor vascular lesions, 10% Lewy body pathology, 5.5% were MIX type dementia, 13% VD with no or only little AD pathology; 8.7% revealed other CNS disorders, and 0.6% displayed no abnormality beyond age-related changes. While the pathogenesis of rare dementia forms, e.g. infections, is well elucidated, for the majority of degenerative dementia disorders including AD/DAT, the etiology and pathogenesis are poorly understood. The morphologic diagnosis and clinico-pathological correlations of degenerative dementias need more standardized criteria; elucidation of their etiology as a basis of treatment strategies is subject of intense current research efforts of basic and clinical neurosciences.

Keywords

Multiple System Atrophy Progressive Supranuclear Palsy Vascular Dementia Progressive Supranuclear Palsy Paired Helical Filament 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Psychiatric Association. Committee on Nomenclature (1987) Diagnostic and statistical manual of mental disorders, 3nd edn, revised. American Psychiatric Association, Washington DC.Google Scholar
  2. Arai H, Schmidt ML, Lee VM-Y, et al (1992) Epitope analysis of senile plaque components in the hippocampus of patients with Parkinson’s disease. Neurology 42:1315–1322.PubMedGoogle Scholar
  3. Armstrong RA, Myers D, Smith CUM (1993) The spatial patterns of plaques and tangles in Alzheimer’s diseases do not support the “cascade hypothesis”. Dementia 4:16–20.PubMedGoogle Scholar
  4. Arnold SE, Kumar A (1993) Reversible dementias. Med Clin North Am 77:215–130.PubMedGoogle Scholar
  5. Arriagada PV, Growdon JH, Hedley-Whyte T, et al (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42:631–639.PubMedGoogle Scholar
  6. Arriagada PV, Marzhoff K, Hyman BT (1993) Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer’s disease. Neurology 42:1681–1688.Google Scholar
  7. Bachmann DL, Wolf PA, Linn RT, Knoefel JE, Cobb JL, Belanger AJ, White LR, D’Agostino RB (1993) Incidence of dementia and probable Alzheimer’s disease in a general population. Ann Neurol 43:515–519.Google Scholar
  8. Bancher C, Grundke-Iqbal K, Fried VA, Smith HT, Wisniewski HM (1990) Abnormal phosphorylation of tau precedes ubiquination of neurofibrillary pathology of Alzheimer’s disease. Brain Res 539:11–18.CrossRefGoogle Scholar
  9. Bancher C, Braak H, Fischer P, Jellinger K (1993) Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer’s and Parkinson’s disease. Neurosci Lett 162:179–182.PubMedCrossRefGoogle Scholar
  10. Bancher C, Jellinger KA (1994) Neurofibrillary tangle predominant form of Alzheimer’s dementia: a rare subtype in very old subjects. Acta Neuro-pathol 88 (in press).Google Scholar
  11. Bancher C, Paulus W, Paukner K, Jellinger K (1993) A questionnaire on the post-mortem diagnosis of Alzheimer’s disease: evidence for lack of consensus between practicing neuropathologists. Clin Neuropathol 12:233.Google Scholar
  12. Bennett DA, Cochran EJ, Saper CB, et al (1993) Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer’s disease. Neurobiol Aging 14:589–596.PubMedCrossRefGoogle Scholar
  13. Benzing WC, Ikonomovic MD, Brady DB, Mufson AJ, Armstrong DM (1993a) Evidence that transmitter-containing dystrophic neurites precede those containing paired helical filaments within senile plaques in the entrohinal cortex of nondemented elderly and Alzheimer’s disease patients. Brain Res 619:55–68.PubMedCrossRefGoogle Scholar
  14. Benzing WC, Ikonomovic MD, Brady DB, Mufson AJ, Armstrong DM (1993b) Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer’s disease. Brain Res 619:55–68.PubMedCrossRefGoogle Scholar
  15. Berg L, McKee DW, Miller JP, Barty J, Morris JC (1993) Neuropathological indices of Alzheimer’s disease in demented and nondemented persons aged 80 years and older. Arch Neurol 50:34–358.CrossRefGoogle Scholar
  16. Bouras C, Hof PR, Morrision JH (1993) Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes. Neurosci Lett 153:131–135.PubMedCrossRefGoogle Scholar
  17. Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239–259.PubMedCrossRefGoogle Scholar
  18. Braak H, Braak E (1992) The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res 15:6–31.PubMedCrossRefGoogle Scholar
  19. Braak H, Braak E (1994) Pathology of Alzheimer’s disease. In: Calne DB (ed) Neurodegenerative disease. Saunders, Philadelphia, pp 585–613.Google Scholar
  20. Braak H, Duyckaerts C, Braak E, Piette F (1993) Neuropathological staging of Alzheimer-related changes correlates with psychometrically assessed intellectual status. In: Corain B, et al (eds) Alzheimer’s disease. Advances in clinical and basic research. Wiley, Chichester, pp 131–137.Google Scholar
  21. Braak H, Braak E, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554–567.PubMedCrossRefGoogle Scholar
  22. Brown P (1994) Transmissible human spongiform encephalopathy (infectious cerebral amyloidosis); Creutzfeldt-Jakob disease, Gerstmann-Sträussler-Scheinker syndrome, and Kuru. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 839–876.Google Scholar
  23. Brun A, Englund B, Gustavson U, et al (1994) Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 57:416–418.CrossRefGoogle Scholar
  24. Cardoso F, Jankovic J (1994) Progressive supranuclear palsy. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 769–786.Google Scholar
  25. Caselli RJ, Scheithauer BW, O’Duffy JD, et al (1993) Chronic inflammatory meningoencephalitis should not be mistaken for Alzheimer’s disease. Mayo Clin Proc 68:846–855.PubMedGoogle Scholar
  26. Chui HC, Tierney M, Zarow C, Lewis A, Sobel E, Perlmutter LS (1993) Neuropathologic diagnosis of Alzheimer disease: interrater reliability in the assessment of senile plaques and neurofibrillary tangles. Alzheimer Dis Assoc Disord 7:48–54.PubMedCrossRefGoogle Scholar
  27. Chui HC, Victoroff JI, Margolin D, et al (1992) Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s disease diagnostic and treatment centers. Neurology 42:473–480.PubMedGoogle Scholar
  28. Cooper PN, Mann DMA (1994) Alpha B-crystallin-immunostaining defines Pick’s disease within lobar atrophy (abstr.) Ann Neurol 36:309.Google Scholar
  29. Coria F, Moreno A, Rubio I, Garcia MA, Morato E, Major Jr F (1993) The cellular pathology associated with Alzheimer β-amyloid deposits in non-demented aged individuals. Neuropathol Appl Neurobiol 19:261–268.PubMedCrossRefGoogle Scholar
  30. Costa C, Duyckaerts C (1993) Oligodendroglial and neuronal inclusions in multiple system atrophy. Curr Opin Neurol 6:865–871.PubMedCrossRefGoogle Scholar
  31. Crystal HA, Dickson DW, Sliwinski MJ, Lipton RB, Grober E, Marks-Nelson H, Antis P (1993) Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol 34:566–573.PubMedCrossRefGoogle Scholar
  32. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive seventy. Ann Neurol 27:457–464.PubMedCrossRefGoogle Scholar
  33. DeKosky ST, Harbaugh RE, Schmitt FA, et al (1992) Cortical biopsy in Alzheimer’s disease: diagnostic accuracy and neurochemical. Neuropathological and cognitive correlations. Ann Neurol 32:625–632.PubMedCrossRefGoogle Scholar
  34. De Lacoste M-C, White C III (1993) The role of cortical connectivity in Alzheimer’s disease pathogenesis; a review and model system. Neurobiol Aging 14:1–16.PubMedCrossRefGoogle Scholar
  35. Delacourte A (1993) The pathophysiological basis of Alzheimer’s disease. Therapie 48:177–183.PubMedGoogle Scholar
  36. Delaere P, Duyckaerts C, He Y, Piette F, Hauw JJ (1991) Subtypes and differential laminar distributions of βA4 deposits in Alzheimer’s disease: relationship with the intellectual status of 26 cases. Acta Neuropathol 81:328–335.PubMedCrossRefGoogle Scholar
  37. Delaere P, He Y, Fayet G, Duyckaerts C, Hauw JJ (1993) β-A4 deposits are constant in the brain of the oldest old. Neurobiol Aging 14:191–194.PubMedCrossRefGoogle Scholar
  38. Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen SH, Aronson MK (1991) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13:179–189.CrossRefGoogle Scholar
  39. Dickson DW, Schmidt ML, Lee VM-Y, et al (1994) Immunoreactive profile of hippocampal CA 2/3 neuntes in Diffuse Lewy body disease. Acta Neuropathol 87:269–276.PubMedCrossRefGoogle Scholar
  40. Dickson DW, Wu E, Crystal HA, Mattiace LA, Yen S-H, Davies P (1992) Alzheimer and age-related pathology in diffuse Lewy body disease. In: Boiler F, et al (eds) Heterogeneity of Alzheimer’s disease. Springer, Berlin Heidelberg New York Tokyo, pp 168–186.Google Scholar
  41. Dippel DWJ, Habbema JDF (1993) Probalistic diagnosis of normal pressure hydrocephalus and other treatable cerebral lesions in dementia. J Neurol Sci 119:123–133.PubMedCrossRefGoogle Scholar
  42. Duyckaerts C, Gaspar P, Costa C, Bonnet AM, Hauw JJ (1993) Dementia in Parkinson’s disease. Morphometric data. Adv Neurol 60:447–455.PubMedGoogle Scholar
  43. Erkinjunnti T, Hachinski VC (1993) Rethinking vascular dementia. Cerebrovasc Disord 3:3–23.CrossRefGoogle Scholar
  44. Esiri MM, Pearson RCA, Steele JE, Bowen DM, Powell TPS (1990) A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 53:161–165.PubMedCrossRefGoogle Scholar
  45. Evans DA, Funkenstein HH, Albert MS, et al (1989) Prevalence of Alzheimer’s disease in a community population of older persons; higher than previsously reported. JAMA 262:2551–2556.PubMedCrossRefGoogle Scholar
  46. Felgenhauer K, Weber T, Poser S (1993) Early clinical and laboratory diagnosis of Creutzfeldt-Jakob disease. Dev Biol Stand 80:125–130.PubMedGoogle Scholar
  47. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12:189–198.CrossRefGoogle Scholar
  48. Fontaine B, Seilhean D, Tourban A, Daumas-Duport C, Duyckaerts C, Benoit N, Devaux B, Hauw JJ, Rancurel G, Lyon-Caen O (1994) Dementia in two histologically confirmed cases of multiple sclerosis: one case with isolated dementia and one case associated with psychiatrc symptoms. J Neurol Neurosurg Psychiatry 57:353–359.PubMedCrossRefGoogle Scholar
  49. Förstl H, Burns A, Luther P, et al (1993) The Lewy body variant of Alzheimer’s disease. Br J Psychiatry 162:385–392.PubMedCrossRefGoogle Scholar
  50. Förstl H, Sattel H, Bahro M (1993) Alzheimer’s disease; clinical features. Int Rev Psychiat 5:327–349.CrossRefGoogle Scholar
  51. Gajdusek DC (1991) The transmissible amyloidoese. Eur J Epidemiol 7:567–577.PubMedCrossRefGoogle Scholar
  52. Garcia JH, Brown GG (1992) Vascular dementia: neuropathologic alterations and metabolic brain changes. J Neurol Sci 109:121–131.PubMedCrossRefGoogle Scholar
  53. Gearing M, Olson DA, Watte RL, Mirra SS (1994) Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology 44:1015–1024.PubMedGoogle Scholar
  54. Goedert M (1993) Tau protein and the neurofibrillary pathology of Alzheimer’s disease. Trends Neurosci 16:460–465.PubMedCrossRefGoogle Scholar
  55. Grant MP, Cohen M, Peterson RR, et al (1993) Abnormal eye movements in Creutzfeldt-Jakob disease. Ann Neurol 34:192–197.PubMedCrossRefGoogle Scholar
  56. Gray F, Dubas F, Roullet E, Escourolle R (1985) Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 18:54–59.PubMedCrossRefGoogle Scholar
  57. Hansen LA, Masliah E, Galasko D, Terry RD (1993) Plaque-only Alzheimer disease is usually the Lewy body variant and vice versa. J Neuropathol Exp Neurol 52:648–654.PubMedCrossRefGoogle Scholar
  58. Hansen L, Salmon D, Galasko D, et al (1990) Lewy body variant of Alzheimer’s disease: a clinical and pathological entity. Neurology 40:1–8.PubMedGoogle Scholar
  59. Harrington CR, Perry RH, Perry BK, et al (1994) Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia 5:215–228.PubMedGoogle Scholar
  60. Hauw JJ, Daniel S, Dickson D, et al (1994) The preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology (in press).Google Scholar
  61. Hof PR, Morrison JH (1994) The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 197–229.Google Scholar
  62. Hofmann A (1993) Epidemiology of Alzheimer’s disease. In: Wolters ECh, Scheltens P (eds) Alzheimer’s disease: back to the future. Vrije Universiteit, Amsterdam, pp 9–20.Google Scholar
  63. Honer WG, Dickson DW, Gleeson J, Davies P (1992) Regional synaptic pathology in Alzheimer’s disease. Neurobiol Aging 13:375–382.PubMedCrossRefGoogle Scholar
  64. Hubbard BM, Fenton GW, Anderson JM (1990) A quantitative histological study of early clinical and preclinical Alzheimer’s disease. Neuropathol Appl Neurobiol 16:111–121.PubMedCrossRefGoogle Scholar
  65. Hyman BT, Tanzi RE (1992) Amyloid, dementia and Alzheimer’s disease. Curr Opin Neurol Neurosurg 5:88–93.PubMedGoogle Scholar
  66. Hyman BT, Van Hoesen GW, Damasio AR (1990) Memory-related neuronal systems in Alzheimer’s disease: an anatomic study. Neurology 40:1721–1730.PubMedGoogle Scholar
  67. Jellinger K (1990) New developments in the pathology of Parkinson’s disease. Adv Neurol 53:1–16.PubMedGoogle Scholar
  68. Jellinger K (1991) Pathology of Parkinson’s disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 14:153–197.PubMedCrossRefGoogle Scholar
  69. Jellinger KA (1993) Morphology of the aging brain and relation to Alzheimer’s disease. In: Calne DB, et al (eds) Advances in research on neuro-degeneration, I. Birkhäuser, Boston, pp 107–137.Google Scholar
  70. Jellinger KA (1994) Quantitative neuropathologic analysis of Pick’s disease. Acta Neuropathol 87:223–224.PubMedCrossRefGoogle Scholar
  71. Jellinger K, Bancher C (1992) Neuropathology. In: Litvan I, Agid Y (eds) Progressive supranuclear palsy. Clinical and research approaches. Oxford University Press, New York, pp 44–88.Google Scholar
  72. Jellinger KA, Bancher C, Fischer P (1993a) Neuropathological correlates of mental dysfunction in Parkinson’s disease. In: Wolters AC, Scheltens P (eds) Mental dysfunction in Parkinson’s disease. Vrije Universiteit, Amsterdam, pp 141–161.Google Scholar
  73. Jellinger K, Braak H, Braak E, Fischer P (1991) Alzheimer lesions in the entorhinal region and isocortex in Parkinson’s and Alzheimer’s diseases. Ann NY Acad Sci 640:203–209.PubMedGoogle Scholar
  74. Jellinger K, Danielczyk W, Fischer P, Gabriel E (1990) Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci 95:239–258.PubMedCrossRefGoogle Scholar
  75. Jellinger KA, Lantos PL, Mehraein P (1993b) Pathological assessment of movement disorders: requirements for documentation in brain banks. J Neural Transm [Suppl] 39:173–184.Google Scholar
  76. Jones RSG (1993) Entorhinal-hippocampal connections: a speculative view of their function. Trends Neurosci 16:58–64.PubMedCrossRefGoogle Scholar
  77. Katzman R, Kawan C (1994) The epidemiology of dementia and Alzheimer disease. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 105–122.Google Scholar
  78. Kazee AM, Eskin TA, Lapham LW, Gabriel RR, McDaniel RD, Hamill RW (1993) Clinicopathologic correlates in Alzheimer’s disease — assessment of clinical and pathologic diagnostic criteria. Alzheimer Dis Assoc Disord 7:152–164.PubMedCrossRefGoogle Scholar
  79. Kennedy PGE, Adams JH, Graham DI, Celements GB (1988) A clinico-pathological study of herpes simplex encephalitis. Neuropathol Appl Neurobiol 14:395–415.PubMedCrossRefGoogle Scholar
  80. Khachaturian ZS (1985) Diagnosis of Alzheimer’s disease. Arch Neurol 42:1097–1105.PubMedCrossRefGoogle Scholar
  81. Killiany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F (1993) Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer’s disease. Arch Neurol 50:949–954.PubMedCrossRefGoogle Scholar
  82. Kosaka K (1993) Dementia and neuropathology in Lewy body disease. Adv Neurol 60:456–463.PubMedGoogle Scholar
  83. Kretzschmar HA (1993) Neuropathology of human Prion diseases (spongiform encephalopathies). Dev Biol Stand 80:71–90.PubMedGoogle Scholar
  84. Lantos PL (1992) Neuropathology of unusual dementias: an overview. In: Rossor MN (ed) Unusual dementias. Baillière’s Clin Neurol 1(3):485–516.Google Scholar
  85. Lantos PL, Papp HI (1994) Cellular pathology of multiple system atrophy; a review. J Neurol Neurosurg Psychiatry 57:129–133.PubMedCrossRefGoogle Scholar
  86. Lang AE, Riley DE, Bergeron C (1994) Cortico-basal ganglionic degeneration. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 877–894.Google Scholar
  87. Lassmann H, Bancher C, Breitschopf H, et al (1994) Cell death in Alzheimer’s disease evaluated by DNA fractionation in situ. Acta Neuropathol (in press).Google Scholar
  88. Lassmann H, Weiler R, Fischer P, Bancher C, Jellinger K, et al (1992) Synaptic pathology in Alzheimer’s disease: immunological data for markers of synaptic and large dense core vesicles. Neuroscience 46:1–8.PubMedCrossRefGoogle Scholar
  89. Lauter H, Kurz A, Haupt B, Romero B, Zimmer R (1990) Clinical diagnosis of Alzheimer’s disease: DSM-III-R, ICD-10 — what else? In: Maurer K, Riederer P, Beckmann H (eds) Alzheimer’s disease. Epidemiology, neuropathology, neurochemistry and clinics. Springer, Wien New York, pp 365–371.Google Scholar
  90. Lehericy S, Hirsch EC, Cervera-Pierot P, et al (1993) Heterogeneity and selectivity of the degenerations of cholinergic neurons in the basal forebrain of patients with Alzheimer’s disease. J Comp Neurol 330:15–31.PubMedCrossRefGoogle Scholar
  91. Leigh PN (1993) Pathogenic mechanisms in amyotrophic lateral sclerosis and other motor neuron disorders. In: Calne DB, et al (eds) Advances in research on neurodegeneration. Birkhäuser, Boston, pp 163–182.Google Scholar
  92. Lennox G, Lowe J, Landon M, et al (1989) Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 52:1236–1247.PubMedCrossRefGoogle Scholar
  93. Liberski PP (1993) The enigma of slow viruses. Facts and artefacts. Arch Virol [Suppl] 6:1–277.CrossRefGoogle Scholar
  94. Lilienfeld DC, Perl DP, Olanow CW (1994) Guam neurodegeneration. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 895–908.Google Scholar
  95. Lippa CF, Smith TW, Swearer JM (1993) Alzheimer’s disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 35:81–88.CrossRefGoogle Scholar
  96. Liszka U, Drlicek M, Hitzenberger P, et al (1993) Wernicke-Enzephalopathie — Klinik und Neuropathologie. Neuropsychiatrie 7:129–132.Google Scholar
  97. Litvan I, Agid Y (eds) (1992) Progressive supranuclear palsy. Clinical and research approaches. Oxford University Press, New York.Google Scholar
  98. Lopez Ol, Larumba MR, Becker JT, Rezek D, Rosen J, Klunk W, Dekosky ST (1994) Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia. Neurology 44:1240–1245.PubMedGoogle Scholar
  99. MacKenzie IRA (1994) Senile plaques do not progressively accumulate with normal aging. Acta Neuropathol 87:520–525.PubMedCrossRefGoogle Scholar
  100. Mann DMA (1994) Pathological correlates of dementia in Alzheimer’s disease. Neurobiol Aging 15:357–360.PubMedCrossRefGoogle Scholar
  101. Mann DMA, South PW, Snowden JP, Neary D (1993) Dementia of frontal lobe type: neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatry 56:605–614.PubMedCrossRefGoogle Scholar
  102. Markesberry WR, Wang HZ, Kowau NW, Kosik KS, McKee AC (1993) Morphometric image analysis of neuropil threads in Alzheimer’s disease. Neurobiol Aging 14:303–307.CrossRefGoogle Scholar
  103. Masliah E, Ellisman M, Carragher M, et al (1992) Three dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer’s disease. J Neuropathol Exp Neurol 51:404–414.PubMedCrossRefGoogle Scholar
  104. Masliah E, Honer WG, Mallory M, et al (1993) Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer’s disease hippocampus. Acta Neuropathol 87:135–142.CrossRefGoogle Scholar
  105. Masliah E, Mallory M, Hansen L, DeTeresa BS, Terry RD (1993) Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 43:192–197.PubMedGoogle Scholar
  106. Masliah E, Mallory M, Deerinck T, et al (1993) Re-evaluation of the structural organization of neuritic plaques in Alzheimer’s disease. J Neuropathol Exp Neurol 52:619–631.PubMedCrossRefGoogle Scholar
  107. Mattson MP, Barger SW, Cheng B, et al (1993) β-amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer’s disease. Trends Neurosci 16:409–414.PubMedCrossRefGoogle Scholar
  108. McKee AC, KosiK KS, Kowall NW (1992) Neuritic pathology and dementia in Alzheimer’s disease. Ann Neurol 30:156–165.CrossRefGoogle Scholar
  109. McKeith IG, Fairbairn AF, Bothwell RA, Moore PB, Ferner IN, Thompson P, Perry RH (1994) An evaluation of the predictive validity and inter-rater reliability of clincial diagnostic criteria for senile dementia of Lewy body type. Neurology 44:5.Google Scholar
  110. McKeel DW, Ball MJ, Price JL, Smith DS, Miller JP, Berg L, Morris JC (1993) Interlaboratory histopathologic assessment of Alzheimer neuropathology — different methodologies yield comparable diagnostic results. Alzheimer Dis Assoc Disord 7:136–151.PubMedCrossRefGoogle Scholar
  111. McKhann GD, Drachmann DA, Folstein MF, et al (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944.PubMedGoogle Scholar
  112. Medori R, Tritschler HJ, LeBlanc A, et al (1992) Fatal familial insomnia, a prion disease with a mutation at codon 178 of the protein gene. N Engl J Med 326:444–449.PubMedCrossRefGoogle Scholar
  113. Mena R, Wischik CM, Novak M, Milstein C, Cuello AC (1991) A progressive deposition of paired helical filaments (PHF) in the brain characterizes the evolution of dementia in Alzheimer’s disease. J Neuropathol Exp Neurol 50:474–490.PubMedCrossRefGoogle Scholar
  114. Mielke R, Herholz K, Grond M, Kessler J, Heiss WD (1992) Severity of vascular dementia is related to volume of metabolically impaired tissue. Arch Neurol 40:909–913.CrossRefGoogle Scholar
  115. Miller JD, Adams JH (1992) The pathophysiology of raised intracranial pressure. In: Adams JH, Duchen LW (eds) Greenfield’s neuropathology, 5th ed. E Arnold, London, pp 69–105.Google Scholar
  116. Mirra SS, Hart MN, Terry RD (1993) Making the diagnosis of Alzheimer’s disease. Arch Pathol Lab Med 117:132–144.PubMedGoogle Scholar
  117. Mirra SS, Gearing M, McKeel DW, Crain BJ, Hughes JP, Van Belle G, Heyman A (1994) Interlaboratory comparison of neuropathology assessments in Alzheimer’s disease: a study of the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). J Neuropathol Exp Neurol 53:303–315.PubMedCrossRefGoogle Scholar
  118. Morris JC, McKeel DW Jr, Storandt M, et al (1991) Very mild Alzheimer’s disease: informant-based clinical, psychometric, and pathological distinction from normal aging. Neurology 41:469–478.PubMedGoogle Scholar
  119. Mulhaupt G, Masters CL, Beyreuther K (1993) A molecular approach to Alzheimer’s disease. Biol Chem Hoppe Seyler 374:1–8.CrossRefGoogle Scholar
  120. Mullan H, Crawford F (1993) Genetic and molecular advances in Alzheimer’s disease. Trends Neurosci 16:398–403.PubMedCrossRefGoogle Scholar
  121. Murayama S, Mori H, Ihaia Y, Tomonaga M (1990) Immunocytochemical and ultrastructural studies of Pick’s disease. Ann Neurol 27:394–405.PubMedCrossRefGoogle Scholar
  122. Papp MI, Kahn JE, Lantos PL (1992) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivo-pontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 107:172–182.PubMedCrossRefGoogle Scholar
  123. Pappola MA, Omar RA, Vinters HV (1991) Image analysis microspectoscopy shows that neurons participate in the genesis of a subset of early primitive (diffuse) senile plaques. Am J Pathol 139:599–607.Google Scholar
  124. Paulus W, Bancher C, Jellinger K (1992) Interrater reliability in the neuro-pathologic diagnosis of Alzheimer’s disease. Neurology 42:329–332.PubMedGoogle Scholar
  125. Paulus W, Selim M (1990) Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles. Acta Neuropathol 81:89–94.PubMedCrossRefGoogle Scholar
  126. Perry EK, Irving D, Kerwin JM, et al (1993) Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson’s and distinction from Alzheimer’s disease. Alzheimer Dis Assoc Disord 7:69–79.PubMedCrossRefGoogle Scholar
  127. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK (1990) Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95:119–139.PubMedCrossRefGoogle Scholar
  128. Pillon B, Michon A, Malapani C, Agid Y, Dubois B (1994) Are explicit memory disorders of progressive subranuclear palsy related to damage in striatofrontal circuits? Comparison with Alzheimer’s, Parkinson’s and Huntington’s diseases. Neurology 44: 1264–1269.PubMedGoogle Scholar
  129. Pohl-Koppe A, Dahm C, Elgas M, et al (1992) The diagnostic significance of the polymerase chain reaction and isoelectric focusing in herpes simplex virus encephalitis. J Med Virol 36:147–154.PubMedCrossRefGoogle Scholar
  130. Price JL, Davis PB, Morris JC, White DL (1992) The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer’s disease. Neurobiol Aging 12:295–312.CrossRefGoogle Scholar
  131. Prusiner SB (1993) Prion pathology. In: Prusiner SB, Collinge J, Powell J, Anderton B (eds) Prion diseases in humans and animals. Harwood, London.Google Scholar
  132. Prusiner SB (1993) Prion encephalopathies of animals and humans. Dev Biol Stand 80:31–44.PubMedGoogle Scholar
  133. Puchhammer-Stöckl E, Heinz FX, Kundl M, et al (1993) Evaluation of the polymerase chain reaction for diagnosis of herpes simplex virus encephalitis. J Clin Microbiol 31:146–148.PubMedGoogle Scholar
  134. Reisberg B, Sclan SG, Franssen E, Deleon MJ, Kluger A, Torossian C, Shulman E, Steinberg G, Monteiro I, Mcrae T, Boksay I, Mackell J, Ferris SH (1993) Clinical stages of normal aging and Alzheimer’s disease — the GDS staging system. Neurosci Res Commun 13:S51–S54.Google Scholar
  135. Reusche E (1991) Silver staining of senile plaques and neurofibrillary tangles in paraffine sections. Pathol Res Pract 187:1045–1049.PubMedCrossRefGoogle Scholar
  136. Roberts GW, Nash M, Ince PG, Roystom MC, Gentleman SM (1993) On the origin of Alzheimer’s disease: a hypothesis. Neuroreport 4:7–9.PubMedCrossRefGoogle Scholar
  137. Roberts GW, Gentleman SM, Lynch A, Murray L, Landon M, Graham DI (1994) γamyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 57:419–425.PubMedCrossRefGoogle Scholar
  138. Roman GC, Tatechimi TK, Erkinjuntti T, et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250–260.PubMedGoogle Scholar
  139. Samuel W, Terry RD, DeTeresa R, Butlers N, Masliah E (1994) Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. Arch Neurol 51:772–778.PubMedCrossRefGoogle Scholar
  140. Scheff SW, Price DA (1993) Synapse loss in the temporal lobe in Alzheimer’s disease. Ann Neurol 33:190–199.PubMedCrossRefGoogle Scholar
  141. Schmidbauer M, Podreka I, Wimberger D, et al (1991) SPECT and MR imaging in herpes simplex encephalitis. J Comput Assist Tomogr 15:811–815.PubMedCrossRefGoogle Scholar
  142. Selkoe DJ (1994) Alzheimer’s disease: a central role for amylois. J Neuropathol Exp Neurol 53:438–447.PubMedCrossRefGoogle Scholar
  143. Sparks DL, Liu H, Scheff SW, et al (1993) Temporal sequence of plaque formation in the cerebral cortex of nondemented individuals. J Neuropathol Exp Neurol 52:135–142.PubMedCrossRefGoogle Scholar
  144. Sutton RC, Lipper MH, Brashear HR (1993) Limbic encephalitis occuring in association with Alzheimer’s disease. J Neurol Neurosurg Psychiatry 56:808–811.PubMedCrossRefGoogle Scholar
  145. Tatemichi TK, Desmond DW, Paik M, et al (1993) Clinical determination of dementia related to stroke. Ann Neurol 33:568–575.PubMedCrossRefGoogle Scholar
  146. Tatemichi TK, Sacktor N, Mayeux R (1994) Dementia associated with cerebrovascular disease, other degenerative diseases, and metabolic disorders. In: Terry RD, Katzman R, Bikc KL (eds) Alzheimer disease. Raven Press, New York, pp 123–166.Google Scholar
  147. Terry RD, Masliah E, Salmon DP (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572–580.PubMedCrossRefGoogle Scholar
  148. Terry RD, Masliah E, Hansen LA (1994) Structural basis of the cognitive-alterations in Alzheimer disease. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 179–196.Google Scholar
  149. Tierney MC, Fischer H, Lewis AJ, et al (1988) The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer’s disease: clinicopathological study of 57 cases. Neurology 38:356–364.Google Scholar
  150. Tolosa E, Duvoisin R, Cruz-Sanchez FF (eds) (1994) Progressive supranuclear palsy: diagnosis, pathology, and therapy. J Neural Transm [Suppl 42].Google Scholar
  151. Tomlinson BE (1992) Ageing and dementias. In: Adams JH, Duchen LW (eds) Greenfield’s neuropathology, 5th ed. E Arnold, London, pp 1284–1410.Google Scholar
  152. Ulrich J, Spillantini MG, Goedert M, Dukas L, Stähelin HB (1992) Abundant neurofibrillary tangles without senile plaques in a subset of patients with senle dementia. Neurodegeneration 1:257–284.Google Scholar
  153. Van Hoesen GW, Hyman BT, Damasio AR (1991) Entorhinal cortex pathology in Alzheimer’s disease. Hippocampus 1:1–8.PubMedCrossRefGoogle Scholar
  154. Vermersch P, Delacourte A, Javoy-Agid F, Hauw JJ, Agid Y (1993) Dementia in Parkinson’s disease, biochemical evidence for cortical involvement using the immunodetection of abnormal tau proteins. Ann Neurol 33:445–450.PubMedCrossRefGoogle Scholar
  155. Vermersch P, Robitaille Y, Bernier L, et al (1994) Biochemical mapping of neurofibrillary degeneration in a case or progressive supranuclear palsy. Acta Neuropathol 87:572–577.PubMedCrossRefGoogle Scholar
  156. Vollmer R, Ferbert A, Thron A (1993) Verlaufsbeobachtung bei paraneoplastischer limbischer Enzephalitis. Nervenarzt 64:659–662.PubMedGoogle Scholar
  157. Vonsattel JP, Myers RH, Stevens TJ, et al (1985) Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol 44:559–577.PubMedCrossRefGoogle Scholar
  158. Wakabayashi K, Oyanagi K, Makifuchi T, Ikuta F, Hamma A, Hamma Y, Horikawa Y, Tokiguchi S (1994) Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol 87:545–553.PubMedCrossRefGoogle Scholar
  159. Watanabe R, Duchen LW (1993) Cerebral amyloid in human prion disease. Neuropathol Appl Neurobiol 19:253–260.PubMedCrossRefGoogle Scholar
  160. West MJ (1993) Regionally specific loss of neurons in the aging human hippocampus. Neurobiol Aging 14:287–293.PubMedCrossRefGoogle Scholar
  161. Wetterling T, Borgis KJ (1993) Vaskuläre Demenz. Ist eine klinische Unterteilung möglich und sinnvoll? Akt Neurol 20:40–48.CrossRefGoogle Scholar
  162. Wolters ECH, Scheltens P (eds) (1993) Alzheimer’s disease: back to the future. Vrije Universiteit, Amsterdam.Google Scholar
  163. Zhan SS, Beyreuter K, Schmitt HP (1993) Vascular dementia in Spatz-Lindenberg’s disease (SLD): cortical synaptophysin immunohistochemistry as compared with dementia of Alzheimer’s type and non-demented controls. Acta Neuropathol 86:259–264.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1994

Authors and Affiliations

  • K. A. Jellinger
    • 1
  • C. Bancher
    • 1
  1. 1.Ludwig Boltzmann Institute of Clinical NeurobiologyLainz HospitalViennaAustria

Personalised recommendations